Preeclampsia-like symptoms induced in mice by fetoplacental expression of STOX1 are reversed by aspirin treatment.
about
Nitroso-redox balance and mitochondrial homeostasis are regulated by STOX1, a pre-eclampsia-associated genePathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiologyPreeclampsia, of mice and women.Treating the dysfunctional placenta.Advances in the pathophysiology of pre-eclampsia and related podocyte injury.The prion protein family: a view from the placentaLandscape of transcriptional deregulations in the preeclamptic placenta.Unravelling the theories of pre-eclampsia: are the protective pathways the new paradigm?Aspirin inhibits expression of sFLT1 from human cytotrophoblasts induced by hypoxia, via cyclo-oxygenase 1.Adaptive mechanisms controlling uterine spiral artery remodeling during the establishment of pregnancy.From Pre-Clinical Studies to Clinical Trials: Generation of Novel Therapies for Pregnancy Complications.Genetic, immune and vasoactive factors in the vascular dysfunction associated with hypertension in pregnancy.Endothelial cell dysfunction and cardiac hypertrophy in the STOX1 model of preeclampsiaHypoxia-inducible miR-210 contributes to preeclampsia via targeting thrombospondin type I domain containing 7A.Tumor-homing peptides as tools for targeted delivery of payloads to the placenta.Mechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia.(Epi)genetics of pregnancy-associated diseasesRecent advances in the understanding of the pathophysiology of preeclampsia.Thrombosis during pregnancy: Risks, prevention, and treatment for mother and fetus--harvesting the power of omic technology, biomarkers and in vitro or in vivo models to facilitate the treatment of thrombosis.Inventory of Novel Animal Models Addressing Etiology of Preeclampsia in the Development of New Therapeutic/Intervention Opportunities.Prediction and prevention of hypertensive disorders of pregnancy.Targeting STOX1 in the therapy of preeclampsia.Resolution of inflammation pathways in preeclampsia-a narrative review.New Models of Pregnancy-Associated Hypertension.Quantification of Gestational Changes in the Uteroplacental Vascular Tree Reveals Vessel Specific Hemodynamic Roles During Pregnancy in Mice.Noncoding RNA-regulated gain-of-function of STOX2 in Finnish pre-eclamptic familiesPersonalized Therapy Against Preeclampsia by Replenishing Placental Protein 13 (PP13) Targeted to Patients With Impaired PP13 Molecule or Function.Aspirin for Prevention of Preeclampsia.Animal models of preeclampsia: translational failings and why.Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia.Genetic Approaches in Preeclampsia.Oxidative Stress in Preeclampsia and Placental Diseases.
P2860
Q24294779-9E01AAF8-9990-416D-835D-106724478FF5Q26865332-CFFBDB2C-EFA8-4175-9790-E9972BEF131FQ33432708-902BF8F2-67FD-4676-994B-37DD80EDA6ECQ33917113-12F7B638-77BD-44D3-BDAE-0F9F25170F74Q33983807-DAF440EA-8AD2-43FA-AABA-DF3F22D9E72BQ34391242-4F689B7B-A3AF-44A9-ADA3-498896423D29Q34778717-69671B5D-2FDB-4389-8D0F-6061DF6F70FAQ35161111-E36B19CF-E865-4D62-8F3D-F3D4FF6DB533Q35178348-F097F04F-62D1-422C-AB2F-6B307A3ECE69Q35207572-58B7E4F8-905E-46A9-BF32-9F25CF06B148Q35813932-5A0EAA56-F58D-4798-8FC9-F0C61721598EQ36268948-04F0F49F-2D19-496A-8FE7-3E934FAB8EB3Q36499633-EFB80B6F-AD3D-450D-B32B-4775CD5CF272Q36500746-67FEF766-2194-42D0-A95E-A6DDE2CB0ED9Q37056248-C7808E44-22EE-4D1E-AAFC-E682321CE530Q37136212-6B3F83C3-282D-4A15-ADF6-E4720F0D40F7Q37158028-1E78B6AB-37EB-49EF-9320-C41EDEF65F10Q37376964-0AD6EF8A-369B-4393-A36F-9687E00A16FFQ38592484-5F16FFF0-04AF-4AB3-BFBA-32620F87F5F5Q38674096-EDE380BC-DB17-46CB-88C8-710E59ED141CQ38930161-E36E754A-4F05-40D2-872B-EB4AE0A510BEQ38991116-1EB2FC70-D491-417D-A769-AE738744ED5BQ39229350-73D4B3FA-D31E-4F20-AAD9-D76845EF0620Q39283914-F581CA09-02E6-4CDD-A222-83B59C4986E3Q39661560-CDABB8B2-C6F1-4CC1-AE8E-9F84B7347EB4Q41337086-164A2DBD-4F04-47A7-8A1F-A9416B2DAF1AQ42373442-FB72FAFC-E21D-4B09-A32C-B3BB1E5A3B93Q43281151-AD5B1EA2-4172-4E8F-87AA-F857369B31D6Q46300987-B4B27D38-A951-474E-B7B2-7040D095CCF6Q46342648-5E50AFF2-7E1E-49C8-9595-E8BDFFB3A575Q49351723-5A263BF4-49BE-47B7-B255-3DFE006980F6Q55334091-479A6B74-E37B-4D40-9B09-5610AB9A12F9
P2860
Preeclampsia-like symptoms induced in mice by fetoplacental expression of STOX1 are reversed by aspirin treatment.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Preeclampsia-like symptoms ind ...... reversed by aspirin treatment.
@ast
Preeclampsia-like symptoms ind ...... reversed by aspirin treatment.
@en
Preeclampsia-like symptoms ind ...... reversed by aspirin treatment.
@nl
type
label
Preeclampsia-like symptoms ind ...... reversed by aspirin treatment.
@ast
Preeclampsia-like symptoms ind ...... reversed by aspirin treatment.
@en
Preeclampsia-like symptoms ind ...... reversed by aspirin treatment.
@nl
prefLabel
Preeclampsia-like symptoms ind ...... reversed by aspirin treatment.
@ast
Preeclampsia-like symptoms ind ...... reversed by aspirin treatment.
@en
Preeclampsia-like symptoms ind ...... reversed by aspirin treatment.
@nl
P2093
P50
P1433
P1476
Preeclampsia-like symptoms ind ...... reversed by aspirin treatment.
@en
P2093
Alexandre Hertig
Anne-Laure Bauchet
Aurélien Ducat
Bruno Passet
Christophe Buffat
Daniel Vaiman
Fabienne le Provost
Françoise Mondon
Guy Germain
Jean-Luc Vilotte
P304
P356
10.1161/HYPERTENSIONAHA.111.202994
P407
P577
2013-01-28T00:00:00Z